These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A new strategy for the prevention of Clostridium difficile infection. Howerton A; Patra M; Abel-Santos E J Infect Dis; 2013 May; 207(10):1498-504. PubMed ID: 23420906 [TBL] [Abstract][Full Text] [Related]
29. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Bassis CM; Theriot CM; Young VB Antimicrob Agents Chemother; 2014 May; 58(5):2767-74. PubMed ID: 24590475 [TBL] [Abstract][Full Text] [Related]
30. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil. Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474 [TBL] [Abstract][Full Text] [Related]
31. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463 [TBL] [Abstract][Full Text] [Related]
32. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection. Lam SW; Bass SN; Neuner EA; Bauer SR Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633 [TBL] [Abstract][Full Text] [Related]
33. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Warren CA; van Opstal E; Ballard TE; Kennedy A; Wang X; Riggins M; Olekhnovich I; Warthan M; Kolling GL; Guerrant RL; Macdonald TL; Hoffman PS Antimicrob Agents Chemother; 2012 Aug; 56(8):4103-11. PubMed ID: 22585229 [TBL] [Abstract][Full Text] [Related]
34. A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection. Sugimoto H; Yoshihara A; Yamamoto T; Sugimoto K Sci Rep; 2020 Dec; 10(1):22061. PubMed ID: 33328505 [TBL] [Abstract][Full Text] [Related]